Regeneron Pharmaceuticals
REGN
#232
Rank
A$143.88 B
Marketcap
A$1,391
Share price
-0.01%
Change (1 day)
28.45%
Change (1 year)

EPS for Regeneron Pharmaceuticals (REGN)

EPS in 2026 (TTM): A$68.20

According to Regeneron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$70.85. In 2025 the company made an earnings per share (EPS) of A$65.02 an increase over its 2024 EPS that were of A$61.65.

EPS history for Regeneron Pharmaceuticals from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$68.204.88%
2025A$65.025.48%
2024A$61.6510.34%
2023A$55.87-8.56%
2022A$61.10-47%
2021A$115.29133.36%
2020A$49.4069.13%
2019A$29.21-14.44%
2018A$34.14100.71%
2017A$17.0131.78%
2016A$12.9138.96%
2015A$9.2972.55%
2014A$5.38-17.55%
2013A$6.53-44.98%
2012A$11.87
2010A-$1.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$10.07-85.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$7.92-88.83%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
A$26.21-63.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.99-95.78%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$3.56-94.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$29.87-57.83%๐Ÿ‡บ๐Ÿ‡ธ USA